Clinical Trial Update: An Explorative Trial to Evaluate the Pharmacodynamic Effect of SPD557 on Reflux Parameters in Refractory GERD Patients [Phase 2]

View source ↗

Summary

Phase 2 exploratory trial evaluating pharmacodynamic effects of SPD557 on reflux parameters in refractory GERD; study terminated with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• SPD557

Snippet

Sponsor: Shire | Conditions: Gastroesophageal Reflux Disease | Phase 2 | Status: TERMINATED | Results posted: 2013-06-07